Earing Protectors Influence on Newborns Preterm Sleep Pattern
NCT ID: NCT03373578
Last Updated: 2017-12-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
24 participants
INTERVENTIONAL
2012-10-31
2016-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
SUPPORTIVE_CARE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
earmuffs
Preterm newborns with earmuffs during the Quiet time
earmuffs
to compare the neonate's sleep with and without earmuffs during Quiet time at the NICU
control
Preterm newborns without earmuffs during de Quiet time
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
earmuffs
to compare the neonate's sleep with and without earmuffs during Quiet time at the NICU
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Preterm Newborns clinically stable;
* Preterm Newborns with no change in hearing screening test;
* Preterm Newborns current weight between 1200 and 2000g.
Exclusion Criteria
* Preterm Newborns in use of invasive mechanical ventilation and noninvasive;
* Preterm Newborns with any type of congenital malformation;
* Preterm Newborns with periventricular hemorrhage grades II, III and IV;
* Preterm Newborns that received Central Nervous System depressant medication and sedative opioid analgesics in the last 24 hours;
* Preterm Newborns using corticoids;
* Preterm Newborn whose mother has a history of illicit drug use during pregnancy
28 Days
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fundação de Amparo à Pesquisa do Estado de São Paulo
OTHER_GOV
Federal University of São Paulo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mavilde da Luz Gonçalves Pedreira
Escola Paulista de Enfermagem
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eliana M Pinheiro, phD
Role: STUDY_DIRECTOR
Federal University of São Paulo
Mônica H Sato, MSc
Role: PRINCIPAL_INVESTIGATOR
Federal University of São Paulo
Mavilde LG Pedreira, phD
Role: STUDY_DIRECTOR
Federal University of São Paulo
Ariane M Avelar, phD
Role: STUDY_CHAIR
Federal University of São Paulo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Federal Uiversity of São Paulo
São Paulo, , Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Unifesp003
Identifier Type: -
Identifier Source: org_study_id